Lucence

📍 Palo Alto, United States🗓 Founded 2016👥 77 employees💰 Last funded May 2023
Biotechnology Research🌐 lucence.com
Website LinkedIn
Lucence is a precision oncology company committed to bringing clarity to cancer care. Lucence makes ultrasensitive non-invasive liquid biopsy tests to provide doctors and their patients life-changing information to enable earlier detection and effective treatment. Headquartered in Palo Alto and Singapore, Lucence supplies personalized cancer care services through twin CLIA-licensed laboratories in the United States and Singapore. For more information, visit www.lucence.com.
2
Total investors
0
Early stage
1
Mid stage
1
Late stage
2016
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Singapore
2
Frequently asked questions
Who invested in Lucence?
Lucence has 2 investors on record on gritt.io, 1 mid-stage and 1 late-stage investors.
When did Lucence last raise funding?
The most recent investment in Lucence recorded on gritt.io was in May 2023.
When was Lucence founded?
Lucence was founded in 2016.
What industry is Lucence in?
Lucence operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Lucence based?
Lucence is headquartered in Palo Alto, United States.